These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10075276)

  • 1. Improved efficacy with nonsimultaneous administration of netilmicin and minocycline against methicillin-resistant Staphylococcus aureus in in vitro and in vivo models.
    Goto Y; Hiramatsu K; Nasu M
    Int J Antimicrob Agents; 1999 Jan; 11(1):39-46. PubMed ID: 10075276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus.
    Lu X; Yang X; Li X; Lu Y; Ren Z; Zhao L; Hu X; Jiang J; You X
    PLoS One; 2013; 8(7):e68053. PubMed ID: 23844154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic efficacy of cefodizime in combination with minocycline against systemic infection caused by methicillin-resistant Staphylococcus aureus in immunocompromised tumour bearing mice].
    Furukawa T; Shimizu C; Uji T; Miyake Y; Hyodo A; Deguchi K
    Jpn J Antibiot; 1993 Apr; 46(4):310-7. PubMed ID: 8515562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of MRSA sepsis treated by the sequential combination therapy netilmycin and minocycline].
    Maesaki S; Mashimoto H; Araki J; Asai S; Sawatari K
    Kansenshogaku Zasshi; 1994 Dec; 68(12):1523-6. PubMed ID: 7876675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. I. Cefotiam plus minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1992 Jun; 45(6):597-604. PubMed ID: 1507393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on the time-difference combination therapy with netilmicin and minocycline in methicillin-resistant Staphylococcus aureus infections].
    Nasu M; Goto Y; Yamasaki T; Hara K; Kohno S; Koga H; Kaku M; Tomono K; Otsubo T; Maesaki S
    Jpn J Antibiot; 1994 Oct; 47(10):1305-17. PubMed ID: 7807692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sun C; Falagas ME; Wang R; Karageorgopoulos DE; Yu X; Liu Y; Cai Y; Liang B; Song X; Liu Z
    J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. II. cefuzonam plus minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1992 Jun; 45(6):605-11. PubMed ID: 1507394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of methicillin-resistant Staphylococcus aureus to minocycline and other antimicrobials.
    Qadri SM; Halim M; Ueno Y; Saldin H
    Chemotherapy; 1994; 40(1):26-9. PubMed ID: 8306812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model.
    Renneberg J; Karlsson E; Nilsson B; Walder M
    J Infect; 1993 May; 26(3):265-77. PubMed ID: 8505561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of minocycline and rifampin against staphylococci.
    Segreti J; Gvazdinskas LC; Trenholme GM
    Diagn Microbiol Infect Dis; 1989; 12(3):253-5. PubMed ID: 2791487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
    Totsuka K; Shiseki M; Kikuchi K; Matsui Y
    J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
    Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
    Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. I. Synergistic action with minocycline].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1991 Dec; 44(12):1386-91. PubMed ID: 1798073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.